Market Size of Vitamin D Therapy Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 7.00 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Vitamin D Therapy Market Analysis
The Vitamin D therapy market size is expected to grow from USD 1.44 billion in 2023 to USD 2.20 billion by 2028, registering a CAGR of 7.00% during the forecast period (2023-2028).
The COVID-19 pandemic helped the vitamin D therapy market to expand more quickly. Vitamin D deficiency is associated with impaired immune response, which can lead to viral infection. Low vitamin D levels are associated with an increased risk of COVID-19 infection. Hence, vitamin D therapy products played a key role during the pandemic. For instance, as per the study report published by Scientific Reports in November 2022, the most significant reduction in COVID-19 infection was seen in veterans with vitamin D blood levels between 0 and 19 ng/ml after supplementation. Compared to White veterans, Black veterans experienced a more significant related COVID-19 risk decrease with supplementation. Hence, the demand for vitamin D therapy products increased during the pandemic, significantly impacting the market. However, as the COVID-19 cases were reduced, the demand for vitamin D therapeutics is unpredictable over the coming years.
The major factors attributing to the market's growth are the presence of a vast patient pool due to a lack of time with sedentary lifestyles and the rapid growth of the aging population. Also, an increased prevalence of malnutrition cases such as osteoporosis and rickets among all age groups in recent years has escalated awareness programs and healthcare expenditure by government authorities across the globe.
The high burden of vitamin D deficiency also impacts the market's growth. For instance, as per the study report published by Edizioni Minerva Medica in May 2022, in the general population of Canton Ticino, Switzerland, vitamin D deficiency was found to be 35.47%, with a significantly higher prevalence in men than in women. The percentage of vitamin deficiency in individuals aged 17 and older is approximately 35.03%; however, it is higher in children and teens aged 0 to 16 when it reaches a substantially higher 43.95%. This shows the high burden of vitamin D deficiency, which is expected to increase demand for vitamin D therapy products and drive the market over the study period.
Furthermore, new product approvals and launches increase the portfolios of the market products, which can drive the market to grow. For instance, in March 2021, DSM launched ampli-D (calcifediol (also known as calcidiol)), a 3 times faster-acting vitamin D supplement in Australia. Ampli-d is a faster and more effective way for Australian consumers to boost vitamin D levels in the body in days and weeks instead of months to support immune health. Thus, the new product approvals and launches are expected to significantly impact the market over the forecast period.
However, the growing consumption of fortified products in public is expected to hinder the market's growth over the forecast period.
